Dr Daejin Abidoye
ArticleRethinking the role of chemotherapy in haematology and oncology – reflections from EHA 2026
As chemotherapy use declines and targeted therapies assume a larger role in cancer treatment, researchers are looking beyond response rates to focus on real-world feasibility and reducing treatment burden for patients.